Anbio Biotechnology Ownership
| NNNN Stock | 39.98 11.52 22.37% |
Anbio Stock Ownership Analysis
The company had not issued any dividends in recent years. To find out more about Anbio Biotechnology Class contact the company at 49 16 0962 47281 or learn more at https://www.anbio.com.Besides selling stocks to institutional investors, Anbio Biotechnology also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Anbio Biotechnology's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Anbio Biotechnology's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Anbio Biotechnology Quarterly Liabilities And Stockholders Equity |
|
About 5.0% of Anbio Biotechnology Class are currently held by insiders. Unlike Anbio Biotechnology's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Anbio Biotechnology's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Anbio Biotechnology's insider trades
Anbio Biotechnology Outstanding Bonds
Anbio Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anbio Biotechnology Class uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anbio bonds can be classified according to their maturity, which is the date when Anbio Biotechnology Class has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Anbio Biotechnology Corporate Filings
| 28th of April 2025 Other Reports | ViewVerify | |
6K | 21st of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 19th of February 2025 Other Reports | ViewVerify | |
| 18th of February 2025 Certification of the accuracy of the financial statements and disclosures | ViewVerify |
Pair Trading with Anbio Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anbio Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anbio Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving together with Anbio Stock
Moving against Anbio Stock
| 0.57 | BCH | Banco De Chile Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Anbio Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anbio Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anbio Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anbio Biotechnology Class to buy it.
The correlation of Anbio Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anbio Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anbio Biotechnology Class moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anbio Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Anbio Biotechnology Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anbio Biotechnology. If investors know Anbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anbio Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.06 | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Anbio Biotechnology Class is measured differently than its book value, which is the value of Anbio that is recorded on the company's balance sheet. Investors also form their own opinion of Anbio Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Anbio Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anbio Biotechnology's market value can be influenced by many factors that don't directly affect Anbio Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anbio Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anbio Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anbio Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.